… are not given antithrombotic therapy for stroke prevention in AF. It is … Anticoagulation for
stroke prevention in AF is costeffective … Atrial Fibrillation Trial of secondary stroke prevention in a …

… of stroke in order to agree to initiate antithrombotic therapy, and patients were willing to endure
4.4 major bleeds in order to prevent one stroke. In … of stroke prevention in atrial fibrillation. …

… of clinical atrial fibrillation. Even though these episodes of atrial fibrillation lasted minutes
to … We proposed the term subclinical atrial fibrillation to describe atrial fibrillation that is …

… prevention of stroke in atrial fibrillation, apixaban, rivaroxaban, and dabigatran have
broadly similar efficacy for the main endpoints, although the endpoints of haemorrhagic stroke, …

Background: Little data exists regarding the effectiveness and safety of rivaroxaban or apixaban
versus warfarin in nonvalvular atrial fibrillation (NVAF) patients treated outside of clinical …

… Event rates during the trial were lower than expected and the combined end point of
bleeding and stroke may have obscured any benefit for stroke prevention in this study. …

… Stroke outcomes in patients with atrial fibrillation (… stroke prevention in AF may currently be
underestimated by existing economic models that do not distinguish between different stroke …

… The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose
warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. …

… Atrial fibrillation (AF) is a very common arrhythmia and significantly increases stroke risk.
This … , or occult, preventing timely detection and treatment. Accordingly, occult AF may cause …

… of atrial fibrillation worldwide has raised concerns about the dire need for effective stroke
prevention … the contemporary issues surrounding stroke prevention in atrial fibrillation from the …